Citing the company's growth possibilities linked to its main medicine, Brukinsa (zanubrutinib), Morgan Stanley assigned ...

Agco (NYSE:AGCO) on Tuesday was rated Equal Weight in new research coverage by analysts at financial-services firm Morgan ...

Axon Enterprise (NASDAQ:AXON) on Tuesday was upgraded to Overweight from a previous investment rating of Equal Weight by ...

A recent investigation uncovered significant regulatory deficiencies within Morgan Stanley's wealth management operations.

Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...

Evercore Inc. hired veteran health-care banker Joseph Modisett as a senior managing director, according to a person briefed ...

MOVEit is a managed file transfer (MFT) tool, used by large companies to securely share sensitive files. In late May 2023, it ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.62, a high estimate of $142 ...

Even a successful appeal would not address Musk’s goal of achieving this voting threshold. To close the gap, Morgan Stanley ...

Wall Street warns of turbulent 2025 as sky-high valuations and challenging conditions may limit equity market gains despite ...

Morgan Stanley got regulatory approval to locate its Middle East headquarters in Saudi Arabia, joining Wall Street rivals ...

Wells Fargo analyst Mike Mayo maintained a Hold rating on Morgan Stanley (MS – Research Report) yesterday and set a price target of $142.00.